Project CBD
MARCH 21, 2023
That’s what appeared to happen in rats injected with the synthetic CB1 agonists WIN55,212‐2 and CP55,940 in a 2010 study 4 and THC and CBD in a 1:1 ratio in a 2011 follow-up study. 268,1-2 (2010): 145-50. While the collective evidence to date is mixed and inconclusive, it’s also incomplete. 5,6 1147-1155. Hearing research vol.
Otherside Farms
JANUARY 23, 2019
abst – 2010). 2010] – PubMed result. abst – 2010). 2010] – PubMed result. Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma (full – 2006). abst – 2006). 2006] – PubMed result. abst – 2010).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Greencamp
AUGUST 16, 2018
The first study I will reference is from 2006, conducted on mice. In 2010, another pre-clinical study was also conducted on mice, and published in the American Journal of Hospice and Palliative Care. All these findings correlate with the conclusions of the scientists who were involved in the mice study from 2010.
Project CBD
FEBRUARY 27, 2023
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. 22,7 (2006): 1269-76. 110,2 (2010): 604-10. It’s not a new idea. 6,4 e18440.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Cannabis Law Report
NOVEMBER 24, 2021
In modern times, medical journals influence a wider group of people than their specific targeted readerships (Smith 2006 ; Entwistle 1995 ), encompassing health and medical journalists who use them as important expert sources for news stories (Entwistle 1995 ; Van Trigt et al. Oxford: Wiley-Blackwell; 2010. In: Cockerham WC, editor.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Expert insights. Personalized for you.
144 
Let's personalize your content